Pegfilgrastim
Top View
- ZIEXTENZO (Pegfilgrastim-Bmez) Is Biosimilar* to NEULASTA® Discontinue ZIEXTENZO in Patients with Serious Allergic Reactions
- INN Working Document 05.179 Update December 2010
- And G-CSF (filgrastim) After Cyclophosphamide (4 G/M2) Enhance the Peripheral Blood Progenitor Cell Harvest: Results of Two Randomized Studies Including 120 Patients
- Neulasta, INN-Pegfilgrastim
- Oncology Drug Reference Guide
- Recommendations for the Use of White Blood Cell Growth Factors: American Society of Clinical Oncology Clinical Practice Guideline Update
- International Nonproprietary Names (Inn) for Biological and Biotechnological Substances
- FILGRASTIM, PEGFILGRASTIM, LIPEGFILGRASTIM SYNONYMS Rg-CSF
- Are All Gfs Equal? How Say I?
- Nyvepria; INN-Pegfilgrastim
- White Blood Cell Colony Stimulating Factors – Value & Balance Exchange Medical Benefit Drug Policy
- Lumicera Specialty Drug List
- (G-Csfs) (Filgrastim, Lenograstim, Lipegfilgrastim and Pegfilgrastim): New Warning Regarding Aortitis
- Hematopoietic Progenitor Cell Mobilization for Autologous Transplantation
- Clinical Medication Policy
- Medications Used in Sarcoma Treatment
- Clinical Medical Policy
- Integrated Safety Profile of Selinexor in Multiple Myeloma